Radiation Oncology/Therapy: Page 59

Copper radiotracers ID tumors, improve survival

By Rebekah Moan

Two copper radionuclides that target the somatostatin receptor overexpressed in neuroendocrine tumors can not only identify tumors but also improve survival, according to new research published in the December issue of the Journal of Nuclear Medicine.

December 20, 2020

IBA adds CBCT to 2 proton therapy centers

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) is adding conebeam CT (CBCT) to proton therapy systems it has installed at Northwestern Medicine Proton Center in Chicago and the Centre Antoine Lacassagne in Nice, France.

December 17, 2020

Shine breaks ground for new headquarters

By AuntMinnie.com staff writers

Shine Medical Technologies has broken ground in Janesville, WI, on a 54,000-sq-ft facility that will serve as its headquarters and a production facility for its new therapeutics division, established in 2019.

December 16, 2020

TRIUMF inks deal for actinium-225 production

By AuntMinnie.com staff writers

Canadian particle accelerator center TRIUMF has entered a collaboration with Fusion Pharmaceuticals for the production of actinium-225, which has potential as a cancer-killing radioisotope.

December 15, 2020

US microbubble destruction may improve TARE response

By Theresa Pablos

Patients with a common form of liver cancer experienced better treatment outcomes in a recent study when clinicians paired transarterial radioembolization (TARE) with microbubble destruction by ultrasound (US) waves, according to early results published on December 15 in Radiology.

December 14, 2020

Physicians often miss rad therapy side effects

By AuntMinnie.com staff writers

Physicians often missed key side effects of radiation therapy in patients with breast cancer who participated in a new study being presented at the 2020 San Antonio Breast Cancer Symposium. Common side effects missed by physicians included pain, itchy skin, swelling, and fatigue.

December 9, 2020

Yom named editor in chief of Red Journal

By AuntMinnie.com staff writers

Radiation oncologist Dr. Sue Yom, PhD, has been named editor in chief of the International Journal of Radiation Oncology, Biology, Physics, also known as the Red Journal, the flagship publication of the American Society for Radiation Oncology.

December 8, 2020

Skipping rad therapy may not hinder breast cancer survival

By Theresa Pablos

Forgoing radiation therapy after breast-conserving surgery may not negatively affect survival outcomes for some women with breast cancer, according to new study data presented at the 2020 San Antonio Breast Cancer Symposium.

December 8, 2020

Point Biopharma to use Lantheus' PyL in clinical trial

By AuntMinnie.com staff writers

Point Biopharma will use Lantheus Medical Imaging's PyL radiopharmaceutical in its phase III clinical trial for patients with metastatic castration-resistant prostate cancer.

December 8, 2020

RayzeBio raises $105M in series B financing

By AuntMinnie.com staff writers

Radiopharmaceutical startup RayzeBio said it has raised $105 million in series B financing to support the development of radiopharmaceuticals for cancer treatment.

December 7, 2020

ITM receives drug master file for gallium generator

By AuntMinnie.com staff writers

German radiopharmaceutical firm ITM Isotopen Technologien has been granted a drug master file by the U.S. Food and Drug Administration for its GeGant germanium-68/gallium-68 generator.

December 7, 2020

Radiation therapy takes toll on prostate cancer patients' finances

By AuntMinnie.com staff writers

Prostate cancer was associated with a significant financial burden for 15% of men with early-stage prostate cancer -- with external-beam radiation therapy causing the biggest hit to the wallet -- in a study published November 30 in the Journal of Urology.

November 30, 2020

Previous Page

Page 59 of 465

Next Page